Table 5.

Cost-Effectiveness Analysis between DTG and EFV Regimens

Characteristics	Type of Regimen
	EFV-Based	DTG-Based
Frequency	81	81
Total Cost ($)	6419121.12	6418953.72
Average Cost ($) Per Patient	79248.41	79246.34
Effectiveness at ≤250copies/mL (%)	50.6	39.5
Effectiveness at ≤100 copies/mL (%)	64.2	46.9
Effectiveness at ≤150 copies/mL (%)	69.1	46.9
Effectiveness at ≤200 copies/mL (%)	71.6	51.9
ACE at ≤50 copies/mL ($/effectiveness)	156617.41	200623.65
ACE at ≤100 copies/mL ($/effectiveness)	123439.89	168968.74
ACE at ≤150 copies/mL ($/effectiveness)	114686.56	168968.74
ACE at ≤200 copies/mL ($/effectiveness)	110682.14	152690.44
ICER at ≤50 copies/mL ($/effectiveness)	18.6486
ICER at ≤100 copies/mL ($/effectiveness)	11.9653
ICER at ≤150 copies/mL ($/effectiveness)	9.3243
ICER at ≤200 copies/mL ($/effectiveness)	10.5076

ACE: Average Cost-Effectiveness Ratio; ICER: Incremental Cost-Effectiveness Ratio